Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Tiziana Life Sciences (TLSA)

Tiziana Life Sciences Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLSA
DateTimeSourceHeadlineSymbolCompany
24/09/202117:51GlobeNewswire Inc.Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021NASDAQ:TLSATiziana Life Sciences Ltd
07/09/202118:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
07/09/202107:00GlobeNewswire Inc.Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer TreatmentNASDAQ:TLSATiziana Life Sciences Ltd
03/09/202117:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
03/09/202111:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
03/09/202107:00GlobeNewswire Inc.Tiziana Life Sciences plc Posting of Scheme Document and Notice of MeetingsNASDAQ:TLSATiziana Life Sciences Ltd
02/09/202111:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
02/09/202107:00GlobeNewswire Inc.Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer TreatmentNASDAQ:TLSATiziana Life Sciences Ltd
02/09/202107:00Business WirePrecision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer TreatmentNASDAQ:TLSATiziana Life Sciences Ltd
20/08/202111:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
20/08/202107:00GlobeNewswire Inc.Tiziana Life Sciences plc files scheme of arrangement to effect a corporate reorganisation and, if approved, the delisting of its ordinary shares in London and the direct listing of common shares in the new parent company of the Tiziana group on NASDAQNASDAQ:TLSATiziana Life Sciences Ltd
17/08/202107:00GlobeNewswire Inc.Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in BrazilNASDAQ:TLSATiziana Life Sciences Ltd
16/08/202118:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
08/07/202113:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
08/07/202112:59GlobeNewswire Inc.Tiziana Life Sciences plc - ADS Ex-Dividend Date Scheduled for July 09, 2021NASDAQ:TLSATiziana Life Sciences Ltd
02/07/202113:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
02/07/202112:58GlobeNewswire Inc.Tiziana Life Sciences plc - Distribution Dates for shares and ADRs in Accustem Sciences LimitedNASDAQ:TLSATiziana Life Sciences Ltd
30/06/202112:38Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
30/06/202111:47GlobeNewswire Inc.Dr Howard Weiner, Chairman of the Tiziana Scientific Advisory Board, to give an interview on Bloomberg Markets at 1.50pm ET t...NASDAQ:TLSATiziana Life Sciences Ltd
25/06/202111:15GlobeNewswire Inc.Tiziana Life Sciences plc (the "Company") Result of Annual General MeetingNASDAQ:TLSATiziana Life Sciences Ltd
23/06/202111:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
23/06/202107:00GlobeNewswire Inc.Tiziana Enters a Collaboration Agreement with FHI Clinical to Conduct a Phase 2 Clinical Trial for Treating Hospitalized Seve...NASDAQ:TLSATiziana Life Sciences Ltd
21/06/202111:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
21/06/202107:00GlobeNewswire Inc.Tiziana Appoints Dr. Kevin Schutz as Vice-President of Regulatory AffairsNASDAQ:TLSATiziana Life Sciences Ltd
17/06/202116:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
17/06/202107:00GlobeNewswire Inc.Tiziana Responds to UK Call for Development of Innovative ‘Take Home’ Treatments for COVID-19 DiseaseNASDAQ:TLSATiziana Life Sciences Ltd
02/06/202111:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
02/06/202107:00GlobeNewswire Inc.Tiziana Life Sciences plc ("Tiziana" or the “Company”) Posting of Notice of Annual General MeetingNASDAQ:TLSATiziana Life Sciences Ltd
26/05/202107:00GlobeNewswire Inc.Tiziana Reports Data Indicating Significant Immunomodulation effects on Immune and Inflammatory Biomarkers with Nasally Admin...NASDAQ:TLSATiziana Life Sciences Ltd
25/05/202111:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
 Showing the most relevant articles for your search:NASDAQ:TLSA

Your Recent History

Delayed Upgrade Clock